China considers ways to speed up time to market imported drugs
[BEIJING] China is considering taking measures that will shorten the time to market for approved imported drugs in an effort to ease a shortage of such medicines, according to the China Food and Drug Administration (CFDA).
The proposed changes to current clinical trial requirements were in response to public demand for new drugs, the CFDA said in a document published on its website on Friday.
The CFDA proposes eliminating a requirement asking applicants who intend to conduct an international multi-centre clinical trial in China for drugs apart from vaccines to obtain prior foreign approval or be currently in phase II or III clinical trials overseas.
Imported drugs would be allowed to directly apply for market authorisation once completing international multi-centre clinical trials, the document said.
High drug costs and a lack of access to the most recent treatments is a major flashpoint in China, where patients often are forced to resort to risky grey markets to get cheaper medicines.
Imported drugs face 3-4 years of reviews on average before being allowed into the Chinese market, compared with about 16 months in the United States, Chinese newspaper The Paper reported on Monday.
Last month, the government updated its list of medicines covered by basic medical insurance schemes, a long-awaited fillip for drugmakers in the world's second-largest drug market where many new drugs have been kept out of patients' reach because of high costs.
REUTERS
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Energy & Commodities
Oil jumps, equities fall as Iran blasts fan Middle East tensions
Gold set for fifth weekly gain as geopolitical risks buoy demand
Oil holds near 3-week low as US sanctions interrupt easing tensions
Seatrium unit ordered to pay US$108 million in arbitration over equipment supply contracts
BP reshapes its leadership team as some executives leave
BHP to decide on future of nickel business by August, trims met coal estimates